The association between parity and type 2 diabetes mellitus: a cross-sectional, community-based study.
Age
Associated factors
Diabetes mellitus
Parity
Sudan
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
04
06
2024
accepted:
25
10
2024
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
epublish
Résumé
Limited published data exist on the association between parity (number of deliveries) and diabetes mellitus (DM). This study was conducted to evaluate the association between parity and type 2 DM (T2DM) among Sudanese women. A multistage sampling survey was conducted in four villages in the River Nile State, Sudan, between July and September 2022. The World Health Organization's three-level stepwise questionnaire was adopted to collect women's sociodemographic characteristics (age, sex, height, weight, marital status, parity, education level, occupation, detailed obstetric history, and family history of T2DM). Multivariate analyses were performed. A total of 397 women were recruited. Their median (interquartile range) age was 45.0 (33.0‒55.7) years. A total of 154 women (38.8%) were nulliparous, whereas 93 (23.4%), 70 (17.6%), and 80 (20.2%) had para 1‒3, 4 or 5, and more than 5, respectively. A total of 112 (28.2%) women had T2DM. In multivariate analysis, older age (adjusted odds ratio, AOR, 1.04, 95%, confidence interval, CI, 1.02‒1.06), high parity (AOR, 1.1, 95% C, 1.01‒1.20), and a family history of DM (AOR, 3.26, 95% CI, 1.98‒5.38) were associated with T2DM. Compared with the nulliparity, para 1‒3 (AOR, 2.33; 95% CI, 1.17‒4.61), para 4 or 5 (AOR, 2.12; 95% CI, 1.04‒4.30), and para > 5 (AOR, 2.16; 95% CI, 1.09‒4.27) were at higher risk of T2DM. In women aged < 50 years, high parity (AOR, 1.22; 95% CI, 1.06‒1.44) was associated with T2DM. Compared with the nulliparous women, para 4 or 5 (AOR, 3.47; 95% CI, 1.16‒10.34) and para > 5 (AOR, 4.63; 95% CI, 1.54‒13.87) were associated with T2DM, whereas para 1‒3 was not associated with T2DM. In the women aged ≥ 50 years, parity and parity groups were not associated with T2DM. There is a high prevalence of T2DM among Sudanese women. Parity and high parity are significant predictors of T2DM among these women in this part of Sudan.
Sections du résumé
BACKGROUND
BACKGROUND
Limited published data exist on the association between parity (number of deliveries) and diabetes mellitus (DM). This study was conducted to evaluate the association between parity and type 2 DM (T2DM) among Sudanese women.
METHOD
METHODS
A multistage sampling survey was conducted in four villages in the River Nile State, Sudan, between July and September 2022. The World Health Organization's three-level stepwise questionnaire was adopted to collect women's sociodemographic characteristics (age, sex, height, weight, marital status, parity, education level, occupation, detailed obstetric history, and family history of T2DM). Multivariate analyses were performed.
RESULTS
RESULTS
A total of 397 women were recruited. Their median (interquartile range) age was 45.0 (33.0‒55.7) years. A total of 154 women (38.8%) were nulliparous, whereas 93 (23.4%), 70 (17.6%), and 80 (20.2%) had para 1‒3, 4 or 5, and more than 5, respectively. A total of 112 (28.2%) women had T2DM. In multivariate analysis, older age (adjusted odds ratio, AOR, 1.04, 95%, confidence interval, CI, 1.02‒1.06), high parity (AOR, 1.1, 95% C, 1.01‒1.20), and a family history of DM (AOR, 3.26, 95% CI, 1.98‒5.38) were associated with T2DM. Compared with the nulliparity, para 1‒3 (AOR, 2.33; 95% CI, 1.17‒4.61), para 4 or 5 (AOR, 2.12; 95% CI, 1.04‒4.30), and para > 5 (AOR, 2.16; 95% CI, 1.09‒4.27) were at higher risk of T2DM. In women aged < 50 years, high parity (AOR, 1.22; 95% CI, 1.06‒1.44) was associated with T2DM. Compared with the nulliparous women, para 4 or 5 (AOR, 3.47; 95% CI, 1.16‒10.34) and para > 5 (AOR, 4.63; 95% CI, 1.54‒13.87) were associated with T2DM, whereas para 1‒3 was not associated with T2DM. In the women aged ≥ 50 years, parity and parity groups were not associated with T2DM.
CONCLUSION
CONCLUSIONS
There is a high prevalence of T2DM among Sudanese women. Parity and high parity are significant predictors of T2DM among these women in this part of Sudan.
Identifiants
pubmed: 39478557
doi: 10.1186/s12902-024-01767-2
pii: 10.1186/s12902-024-01767-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
233Informations de copyright
© 2024. The Author(s).
Références
Rahmawati. IDF Diabetes Atlas 2021 _ IDF Diabetes Atlas. IDF Off website. 2021;:1–4.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. <ArticleTitle Language=“En”>IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
doi: 10.1016/j.diabres.2021.109119
pubmed: 34879977
Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88:1254–64.
doi: 10.2522/ptj.20080020
pubmed: 18801858
pmcid: 3870323
Stuebe AM, Mantzoros C, Kleinman K, Gillman MW, Rifas-Shiman S, Seely EW, et al. Gestational glucose tolerance and maternal metabolic profile at 3 years postpartum. Obstet Gynecol. 2011;118:1065–73.
doi: 10.1097/AOG.0b013e3182325f5a
pubmed: 22015874
pmcid: 3268071
Fowler-Brown AG, De Boer IH, Catov JM, Carnethon MR, Kamineni A, Kuller LH, et al. Parity and the association with diabetes in older women. Diabetes Care. 2010;33:1778–82.
doi: 10.2337/dc10-0015
pubmed: 20424225
pmcid: 2909061
Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, Powe NR. Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2006;29:2349–54.
doi: 10.2337/dc06-0825
pubmed: 17065666
Araneta MRG, Barrett-Connor E. Grand multiparity is associated with type 2 diabetes in Filipino American women, independent of visceral fat and adiponectin. Diabetes Care. 2010;33:385–9.
doi: 10.2337/dc09-1477
pubmed: 19918009
Guo P, Zhou Q, Ren L, Chen Y, Hui Y. Higher parity is associated with increased risk of Type 2 diabetes mellitus in women: A linear dose-response meta-analysis of cohort studies. J Diabetes Complications. 2017;31:58–66.
doi: 10.1016/j.jdiacomp.2016.10.005
pubmed: 28340964
Li P, Shan Z, Zhou L, Xie M, Bao W, Zhang Y, et al. Mechanisms In Endocrinology: Parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Endocrinol. 2016;175:R231–45.
doi: 10.1530/EJE-16-0321
pubmed: 27334332
Tian Y, Shen L, Wu J, Chen W, Yuan J, Yang H, et al. Parity and the risk of diabetes mellitus among Chinese women: a cross-sectional evidence from the Tongji-Dongfeng cohort study. PLoS ONE. 2014;9:e104810.
doi: 10.1371/journal.pone.0104810
pubmed: 25105792
pmcid: 4126778
Mueller NT, Mueller NJ, Odegaard AO, Gross MD, Koh WP, Yuan JM, et al. Higher parity is associated with an increased risk of type-II diabetes in Chinese women: the Singapore Chinese Health Study. BJOG. 2013;120:1483–9.
doi: 10.1111/1471-0528.12364
pubmed: 23786390
pmcid: 4038299
Hanley AJG, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TMS, Kwan J, et al. Association of parity with risk of type 2 diabetes and related metabolic disorders. Diabetes Care. 2002;25:690–5.
doi: 10.2337/diacare.25.4.690
pubmed: 11919126
Manson JE, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Arky RA, et al. Parity and incidence of non-insulin-dependent diabetes mellitus. Am J Med. 1992;93:13–8.
doi: 10.1016/0002-9343(92)90674-Z
pubmed: 1626567
Iversen DS, Støy J, Kampmann U, Voss TS, Madsen LR, Møller N, et al. Parity and type 2 diabetes mellitus: a study of insulin resistance and β-cell function in women with multiple pregnancies. BMJ open diabetes Res care. 2016;4:e000237.
doi: 10.1136/bmjdrc-2016-000237
pubmed: 27648289
pmcid: 5013461
Omar SM, Musa IR, ElSouli A, Adam I. Prevalence, risk factors, and glycaemic control of type 2 diabetes mellitus in eastern Sudan: a community-based study. Ther Adv Endocrinol Metab. 2019;10:2042018819860071.
doi: 10.1177/2042018819860071
pubmed: 31275546
pmcid: 6598316
Eltom MA, Babiker Mohamed AH, Elrayah-Eliadarous H, Yassin K, Noor SK, Elmadhoun WM, et al. Increasing prevalence of type 2 diabetes mellitus and impact of ethnicity in north Sudan. Diabetes Res Clin Pract. 2018;136:93–9.
doi: 10.1016/j.diabres.2017.11.034
pubmed: 29203255
Alsammani MA, Jafer AM, Khieri SA, Ali AO, Shaaeldin MA. Effect of Grand Multiparity on Pregnancy Outcomes in Women Under 35 Years of Age: a Comparative Study. Med Arch (Sarajevo, Bosnia Herzegovina). 2019;73:92–6.
Sudan – 5th Sudan Population and Housing Census. 2008 - IPUMS Subset. https://microdata.worldbank.org/index.php/catalog/1014 . Accessed 24 Jul 2023.
Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31.
doi: 10.4103/sja.SJA_543_18
pubmed: 30930717
pmcid: 6398292
Riley L, Guthold R, Cowan M, Savin S, Bhatti L, Armstrong T, et al. The world health organization STEPwise approach to noncommunicable disease risk-factor surveillance: Methods, challenges, and opportunities. Am J Public Health. 2016;106:74–8.
doi: 10.2105/AJPH.2015.302962
pubmed: 26696288
pmcid: 4695948
Glycemic targets. standards of medical care in Diabetesd2018. Diabetes Care. 2018;41(Suppl 1):S55–64.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.
doi: 10.1038/s41581-019-0244-2
pubmed: 32024986
pmcid: 7998524
WHO Consultation on Obesity (1999. Geneva, Switzerland) & World Health Organization. (2000). Obesity: preventing and managing the global epidemic : report of a WHO consultation. World Health Organization. https://iris.who.int/handle/10665/42330
OpenEpi Menu. https://www.openepi.com/Menu/OE_Menu.htm . Accessed 24 Mar 2023.
Cure P, Hoffman HJ, Cure-Cure C. Parity and diabetes risk among hispanic women from Colombia: cross-sectional evidence. Diabetol Metab Syndr. 2015;7. https://doi.org/10.1186/s13098-015-0001-z .
Naver KV, Lundbye- Christensen S, Gorst- Rasmussen A, Nilas L, Secher NJ, Rasmussen S, et al. Parity and risk of diabetes in a Danish nationwide birth cohort. Diabet Med. 2011;28:43–7.
doi: 10.1111/j.1464-5491.2010.03169.x
pubmed: 21166844
Moazzeni SS, Hizomi Arani R, Asgari S, Azizi F, Hadaegh F. The association of parity/live birth number with incident type 2 diabetes among women: over 15 years of follow-up in The Tehran Lipid and Glucose Study. BMC Womens Health. 2021;21. https://doi.org/10.1186/s12905-021-01519-7 .
Huo Y, Cheng L, Wang C, Deng Y, Hu R, Shi L, et al. Associations between parity, pregnancy loss, and breastfeeding duration and risk of maternal type 2 diabetes: An observational cohort study. J Diabetes. 2021;13:857–67.
doi: 10.1111/1753-0407.13176
pubmed: 33710784
Abdelsalam KEA, Elamin AAM. Influence of Grand Multiparity on the Levels of Insulin, Glucose and HOMA-IR in Comparison with Nulliparity and Primiparity. Pakistan J Biol Sci PJBS. 2017;20:42–6.
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (London England). 2009;373:1773–9.
doi: 10.1016/S0140-6736(09)60731-5
pubmed: 19465232
Kampmann U, Knorr S, Fuglsang J, Ovesen P. Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview. J Diabetes Res. 2019;2019:5320156.
doi: 10.1155/2019/5320156
pubmed: 31828161
pmcid: 6885766
Derakhshan A, Tohidi M, Hajebrahimi MA, Saadat N, Azizi F, Hadaegh F. Sex-specific incidence rates and risk factors of insulin resistance and β-cell dysfunction: a decade follow-up in a Middle Eastern population. Diabet Med. 2017;34:245–52.
doi: 10.1111/dme.13117
pubmed: 26996519
Mosorin ME, Ollila MM, Nordström T, Jokelainen J, Piltonen T, Auvinen J, et al. Former long-term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population-based cohort study. Acta Obstet Gynecol Scand. 2023;102:1488–95.
doi: 10.1111/aogs.14636
pubmed: 37568273
pmcid: 10577621
Aguayo-Mazzucato C, Diaque P, Hernandez S, Rosas S, Kostic A, Caballero AE. Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States. Diabetes Metab Res Rev. 2019;35:e3097.
doi: 10.1002/dmrr.3097
pubmed: 30445663
Langenberg C, Lotta LA. Genomic insights into the causes of type 2 diabetes. Lancet. 2018;391:2463–74.
doi: 10.1016/S0140-6736(18)31132-2
pubmed: 29916387
Sun MH, Wen ZY, Wang R, Gao C, Yin JL, Chang YJ, et al. Parity and Metabolic Syndrome Risk: A Systematic Review and Meta-Analysis of 15 Observational Studies With 62,095 Women. Front Med. 2022;9:926944.
doi: 10.3389/fmed.2022.926944
Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016;37:278.
doi: 10.1210/er.2015-1137
pubmed: 27159875
pmcid: 4890267
Tyrovolas S, Koyanagi A, Garin N, Olaya B, Ayuso-Mateos JL, Miret M, et al. Diabetes mellitus and its association with central obesity and disability among older adults: a global perspective. Exp Gerontol. 2015;64:70–7.
doi: 10.1016/j.exger.2015.02.010
pubmed: 25688991
Mordarska K, Godziejewska-Zawada M. Diabetes in the elderly. Prz menopauzalny = Menopause Rev. 2017;16:38–43.
doi: 10.5114/pm.2017.68589
Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab. 2003;284:E7–12.
doi: 10.1152/ajpendo.00366.2002
pubmed: 12485807
Krentz AJ, Viljoen A, Sinclair A. Insulin resistance: a risk marker for disease and disability in the older person. Diabet Med. 2013;30:535–48.
doi: 10.1111/dme.12063
pubmed: 23173973
Cignarella A, Bolego C, Cignarella A. Mechanisms of estrogen protection in diabetes and metabolic disease. Horm Mol Biol Clin Investig. 2010;4:575–80.
doi: 10.1515/HMBCI.2010.084
pubmed: 25961234
Catalano PM. Trying to understand gestational diabetes. Diabet Med. 2014;31:273.
doi: 10.1111/dme.12381
pubmed: 24341419
pmcid: 4178541
Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study. Diabetes Care. 2013;36:1994–2000.
doi: 10.2337/dc12-1870
pubmed: 23315604
pmcid: 3687317
Abbasi A, Corpeleijn E, Meijer E, Postmus D, Gansevoort RT, Gans ROB, et al. Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia. 2012;55:1963–70.
doi: 10.1007/s00125-012-2545-x
pubmed: 22526609
Jayabalan N, Nair S, Nuzhat Z, Rice GE, Zuñiga FA, Sobrevia L et al. Cross talk between adipose tissue and placenta in obese and gestational diabetes mellitus pregnancies via exosomes. Front Endocrinol (Lausanne). 2017;8 SEP:239.
Salomon C, Scholz-Romero K, Sarker S, Sweeney E, Kobayashi M, Correa P, et al. Gestational Diabetes Mellitus Is Associated With Changes in the Concentration and Bioactivity of Placenta-Derived Exosomes in Maternal Circulation Across Gestation. Diabetes. 2016;65:598–609.
doi: 10.2337/db15-0966
pubmed: 26718504